VF
AGTC

Virtu Financial’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Virtu Financial’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-116,488
Closed -$32K – 2544
2022
Q3 		$32K Buy
116,488
+105,681
+978% +$46.1K ﹤0.01% 1303
2022
Q2 		$8K Sell
10,807
-59,310
-85% -$52.9K ﹤0.01% 1442
2022
Q1 		$75K Buy
+70,117
New +$127K 0.01% 1040
2021
Q2 		– Sell
-12,448
Closed -$63K – 2292
2021
Q1 		$63K Sell
12,448
-36,230
-74% -$188K ﹤0.01% 1404
2020
Q4 		$199K Buy
+48,678
New +$239K 0.02% 864
2020
Q3 		– Sell
-11,499
Closed -$64K – 1697
2020
Q2 		$64K Buy
+11,499
New +$52.7K 0.01% 972
2019
Q3 		– Sell
-10,220
Closed -$39K – 1972
2019
Q2 		$39K Buy
+10,220
New +$41.9K ﹤0.01% 1278

Virtu Financial's AGTC Position: Q4 2022 in Review

Virtu Financial sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 116,488 shares — an estimated $32K sold.

Virtu Financial first reported a position in AGTC in Q2 2019 and held it in 7 quarters. The position peaked at $199K in Q4 2020. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Virtu Financial reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Virtu Financial sold 116,488 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $32K.
  • Virtu Financial first reported a position in Applied Genetic Technologies Corporation in Q2 2019 and held it in 7 quarters.
  • Virtu Financial's Applied Genetic Technologies Corporation position peaked at $199K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.